SC
ONC

Slow Capital’s BeOne Medicines Ltd ONC Stock Holding History

Slow Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.05M Sell
28,237
-255
-0.9% -$75.1K 0.94% 31
2026
Q1 		$8.46M Buy
28,492
+1,191
+4% +$386K 1.1% 24
2025
Q4 		$8.29M Buy
27,301
+9,280
+51% +$3.04M 0.99% 28
2025
Q3 		$6.14M Sell
18,021
-62
-0.3% -$18.8K 0.72% 37
2025
Q2 		$4.38M Buy
18,083
+5,846
+48% +$1.43M 0.54% 54
2025
Q1 		$3.33M Buy
+12,237
New +$2.86M 0.45% 69

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Slow Capital's ONC Position: Q2 2026 in Review

Slow Capital reduced its BeOne Medicines Ltd (ONC) stake by 0.89% in Q2 2026, selling an estimated $75.1K and leaving 28,237 shares worth $8.05M. The position accounts for 0.94% of the portfolio, ranked #31.

Slow Capital first reported a position in ONC in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.46M in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Slow Capital held 28,237 shares of BeOne Medicines Ltd worth $8.05M as of Q2 2026.
  • Slow Capital sold 255 BeOne Medicines Ltd shares in Q2 2026, an estimated $75.1K.
  • BeOne Medicines Ltd made up 0.94% of Slow Capital's portfolio in Q2 2026, its #31 holding.
  • Slow Capital first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 6 quarters since.
  • Slow Capital's BeOne Medicines Ltd position peaked at $8.46M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Slow Capital's 13F filing for Q2 2026, filed 22 Jul 2026.